Patient-centric delivery systems, supply chain resilience, and sustainability initiatives are three trends driving growth in the sterile-fill-finish space, according to CEO Nick Buschur. Nick shared his thoughts on the latest trends shaping the market in the latest issue of Contract Pharma.
Get Nick’s insight at: